Osteoclast growth regulating factors and antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 4, 1997
Issued Date -
N/A
app pub date -
Jul 25, 1994
filing date -
Jul 23, 1991
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to a novel osteoclast growth regulatory factor, hereinafter referred to as 'osteoclastpoietic factor (OPF),' which stimulates the formation of osteoclast bone cells, a process of preparing same, therapeutic and diagnostic uses thereof, antibodies to and antagonists of OPF, and assays for OPF, all of which relate to the development of therapeutics for the prevention and treatment of diseases involving bone tissue, for example, osteoporosis, Paget's disease and osteopetrosis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully